Opacity Labs, Inc. – Trademark Portfolio
Entity Type: 03
Opacity Labs, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 11 are pending. Notable registered marks include OPACITY and VERIFIED DATA NETWORK (VDN). The owner is based in New York, NY.
1460 Broadway
17th Floor
New York, NY 10036
Showing of trademarks Trademarks
Trademark Classifications
Opacity Labs, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Opacity Labs, Inc. have?
Opacity Labs, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 2 registered, 11 pending.
What trademark classes does Opacity Labs, Inc. file in?
Opacity Labs, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Opacity Labs, Inc.'s most well-known trademarks?
Opacity Labs, Inc.'s registered trademark portfolio includes well-known marks such as OPACITY and VERIFIED DATA NETWORK (VDN). These are among 2 currently registered trademarks in the portfolio.
What is Opacity Labs, Inc.'s trademark registration success rate?
Opacity Labs, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 11 applications are pending review.